Viewing Study NCT02120404


Ignite Creation Date: 2025-12-24 @ 9:07 PM
Ignite Modification Date: 2026-01-05 @ 5:46 PM
Study NCT ID: NCT02120404
Status: UNKNOWN
Last Update Posted: 2023-08-31
First Post: 2014-04-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Phase II Study: Hemodynamic Tolerance and Anti-inflammatory Effects of Esmolol During the Treatment of Septic Shock
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module